These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4915108)

  • 1. [Experimental-psychologic study of performance changes through perazine (Taxilan) in mentally disturbed and healthy people following regular or one time treatment].
    Junker E
    Nervenarzt; 1970 Mar; 41(3):118-23. PubMed ID: 4915108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improved cerebral circulation and increment performance in a psychologic experiment].
    Köhler W
    Nervenarzt; 1970 Apr; 41(4):181-7. PubMed ID: 4914870
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychological methods applied to evaluate symptomatic geriatric treatment.
    Lourander L; Ruikka I; Rautakorpi J
    Geriatrics; 1970 Aug; 25(8):124 passim. PubMed ID: 4914065
    [No Abstract]   [Full Text] [Related]  

  • 5. A preliminary study of SKF-14,336 in chronic schizophrenia.
    Simpson GM; Iqbal J; Iqbal F
    Curr Ther Res Clin Exp; 1966 Sep; 8(9):447-51. PubMed ID: 4957931
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of psychological methods for studying the particular psychotropic action of various psychopharmacologic drugs].
    Os'makova EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(11):1705-8. PubMed ID: 4576060
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients.
    Spiegel DE; Keith-Spiegel P
    J Nerv Ment Dis; 1967 Feb; 144(2):111-6. PubMed ID: 5338760
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parenteral form of pipothiazine in the treatment of endogenous psychoses].
    Matkowski K; Martenka E; Nobis T
    Psychiatr Pol; 1984; 18(6):567-70. PubMed ID: 6152666
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between the hospital milieu and the response to phenothiazines in the treatment of schizophrenics.
    Klerman GL; Goldberg SG; Davis D
    Acta Psychiatr Belg; 1970 Nov; 70(6):716-29. PubMed ID: 4931261
    [No Abstract]   [Full Text] [Related]  

  • 10. [Performance of normally intelligent children with organically reduced cerebral capacity under the effect of cerutil in a task performing experiment].
    Teichmann H; Schwebke R
    Psychiatr Neurol Med Psychol (Leipz); 1973 May; 25(3):168-77. PubMed ID: 4145958
    [No Abstract]   [Full Text] [Related]  

  • 11. Carphenazine in the intensive care of chronically ill psychotics.
    Hanenson I
    Int J Neuropsychiatry; 1967 Aug; 3(4):332-6. PubMed ID: 4863506
    [No Abstract]   [Full Text] [Related]  

  • 12. Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study.
    Sterlin C; Augustin E; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):50-2. PubMed ID: 4992566
    [No Abstract]   [Full Text] [Related]  

  • 13. Time relations of the effects of alcohol compared to placebo. Dose-response curves for psychomotor and perceptual test performances and blood and urine levels of alcohol.
    Ideström CM; Cadenius B
    Psychopharmacologia; 1968 Sep; 13(3):189-200. PubMed ID: 4878383
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 15. Marihuana-induced "high": influence of expectation, setting and previous drug experience.
    Jones RT
    Pharmacol Rev; 1971 Dec; 23(4):359-69. PubMed ID: 4943950
    [No Abstract]   [Full Text] [Related]  

  • 16. Agranulocytosis and phenothiazines.
    Mandel A; Gross M
    Dis Nerv Syst; 1968 Jan; 29(1):32-6. PubMed ID: 5635744
    [No Abstract]   [Full Text] [Related]  

  • 17. Weight as a correlate of clinical response to psychotropic drugs.
    Singh MM; De Dios LV; Kline NS
    Psychosomatics; 1970; 11(6):562-70. PubMed ID: 4923004
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal of ataractic medication in schizophrenic patients.
    Garfield SL; Gershon S; Sletten I; Neubauer H; Ferrel E
    Dis Nerv Syst; 1966 May; 27(5):321-5. PubMed ID: 5327466
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentric clinical evaluation of pimozide. Preliminary report.
    Brugmans J
    Acta Neurol Psychiatr Belg; 1968; 68(12):875-87. PubMed ID: 4976735
    [No Abstract]   [Full Text] [Related]  

  • 20. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.